| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |